| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to … C Fitzmaurice, C Allen, RM Barber, L Barregard, ZA Bhutta, H Brenner, ... JAMA oncology 3 (4), 524-548, 2017 | 7574 | 2017 |
| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ... The lancet 396 (10258), 1204-1222, 2020 | 7088 | 2020 |
| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The lancet 396 (10258), 1223-1249, 2020 | 5474 | 2020 |
| Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 VL Feigin, E Nichols, T Alam, MS Bannick, E Beghi, N Blake, ... The Lancet Neurology 18 (5), 459-480, 2019 | 2385* | 2019 |
| The epidemiology of glioma in adults: a “state of the science” review QT Ostrom, L Bauchet, FG Davis, I Deltour, JL Fisher, CE Langer, ... Neuro-oncology 16 (7), 896-913, 2014 | 2287 | 2014 |
| Epidemiology and molecular pathology of glioma JA Schwartzbaum, JL Fisher, KD Aldape, M Wrensch Nature clinical practice Neurology 2 (9), 494-503, 2006 | 1219 | 2006 |
| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 996 | 2022 |
| Epidemiology of brain tumors JL Fisher, JA Schwartzbaum, M Wrensch, JL Wiemels Neurologic clinics 25 (4), 867-890, 2007 | 685 | 2007 |
| Five insights from the global burden of disease study 2019 CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ... The Lancet 396 (10258), 1135-1159, 2020 | 581 | 2020 |
| Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global … R Lozano, N Fullman, JE Mumford, M Knight, CM Barthelemy, C Abbafati, ... The Lancet 396 (10258), 1250-1284, 2020 | 535 | 2020 |
| Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review KJ Johnson, J Cullen, JS Barnholtz-Sloan, QT Ostrom, CE Langer, ... Cancer Epidemiology, Biomarkers & Prevention 23 (12), 2716-2736, 2014 | 425 | 2014 |
| Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 AP Patel, JL Fisher, E Nichols, F Abd-Allah, J Abdela, A Abdelalim, ... The Lancet Neurology 18 (4), 376-393, 2019 | 371 | 2019 |
| Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global … KR Paulson, AM Kamath, T Alam, K Bienhoff, GG Abady, J Abbas, ... The Lancet 398 (10303), 870-905, 2021 | 312 | 2021 |
| Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis JP Rock, D Hearshen, L Scarpace, D Croteau, J Gutierrez, JL Fisher, ... Neurosurgery 51 (4), 912-920, 2002 | 286 | 2002 |
| Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma D Croteau, L Scarpace, D Hearshen, J Gutierrez, JL Fisher, JP Rock, ... Neurosurgery 49 (4), 823-829, 2001 | 270 | 2001 |
| Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis JP Rock, L Scarpace, D Hearshen, J Gutierrez, JL Fisher, M Rosenblum, ... Neurosurgery 54 (5), 1111-1119, 2004 | 244 | 2004 |
| Rural residence and cancer outcomes in the United States: issues and challenges A Meilleur, SV Subramanian, JJ Plascak, JL Fisher, ED Paskett, ... Cancer epidemiology, biomarkers & prevention 22 (10), 1657-1667, 2013 | 234 | 2013 |
| Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan–Riley–Ruvalcaba syndrome clinical features R Pilarski, JA Stephens, R Noss, JL Fisher, TW Prior Journal of medical genetics 48 (8), 505-512, 2011 | 197 | 2011 |
| Evaluation of web-based, self-administered, graphical food frequency questionnaire AR Kristal, AS Kolar, JL Fisher, JJ Plascak, PJ Stumbo, R Weiss, ... Journal of the Academy of Nutrition and Dietetics 114 (4), 613-621, 2014 | 181 | 2014 |
| Incidence and survival in sarcoma in the United States: a focus on musculoskeletal lesions VY Ng, TJ Scharschmidt, JL Mayerson, JL Fisher Anticancer research 33 (6), 2597-2604, 2013 | 150 | 2013 |
